Page last updated: 2024-08-17
levodopa and CDN1163
levodopa has been researched along with CDN1163 in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Dahl, R | 1 |
Other Studies
1 other study(ies) available for levodopa and CDN1163
| Article | Year |
|---|---|
A new target for Parkinson's disease: Small molecule SERCA activator CDN1163 ameliorates dyskinesia in 6-OHDA-lesioned rats.
Topics: Aminoquinolines; Animals; Benzamides; Calcium; Cell Death; Drug Discovery; Dyskinesias; Endoplasmic Reticulum Stress; Enzyme Activators; Male; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Wistar; Sarcoplasmic Reticulum Calcium-Transporting ATPases | 2017 |